Financials
Income statement
| Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|
| Total reported revenue | 21.9B | 21.7B | 20.5B | 20.2B |
| Cost of revenue | 10.4B | 10.4B | 10.3B | 9.9B |
| Gross profit | 11.5B | 11.3B | 10.2B | 10.3B |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 5.7B | 5.5B | 6.3B | 5.9B |
| Other operating expenses | — | — | — | — |
| Operating income | 5.7B | 5.8B | 3.9B | 4.5B |
| Non operating interest income | ||||
| Income | 119M | 135M | 107M | 104M |
| Expense | 240M | 238M | 220M | 233M |
| Other income expense | 224M | -554M | 98M | 260M |
| Pretax income | 5.8B | 5.1B | 3.9B | 4.6B |
| Tax provision | 1.2B | 1.2B | 726M | 812M |
| Net income | 4.7B | 4.0B | 3.1B | 3.8B |
| Basic EPS | 1.9 | 1.7 | — | 1.6 |
| Diluted EPS | 1.9 | 1.6 | — | 1.5 |
| Basic average shares | 119.9M | 120.1M | — | 120.3M |
| Diluted average shares | 125.3M | 125.7M | — | 126.0M |
| EBITDA | 6.8B | 6.1B | 4.9B | 5.5B |
| Net income from continuing op. | 4.7B | 4.0B | 3.1B | 3.8B |
| Minority interests | -29M | -28M | -7M | -27M |
| Preferred stock dividends | — | — | — | — |